|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/195 | (2006.01) |
| A61K 31/197 | (2006.01) | ||
| A61P 35/04 | (2006.01) |
| (11) | Number of the document | 3432872 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17770846.8 |
| Date of filing the European patent application | 2017-03-16 | |
| (97) | Date of publication of the European application | 2019-01-30 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/022718 |
| Date | 2017-03-16 |
| (87) | Number | WO 2017/165187 |
| Date | 2017-09-28 |
| (30) | Number | Date | Country code |
| 201662312623 P | 2016-03-24 | US |
| (72) |
LEVIN, Victor, A. , US
|
| (73) |
Orbus Therapeutics, Inc. ,
2475 East Bayshore Road
Suite 105, Palo Alto, CA 94303,
US
|
| (54) | EFLORNITHINE FOR USE IN THE TREATMENT OF TEMOZOLOMIDE RECURRENT/REFRACTORY ANAPLASTIC ASTROCYTOMA |
| EFLORNITHINE FOR USE IN THE TREATMENT OF TEMOZOLOMIDE RECURRENT/REFRACTORY ANAPLASTIC ASTROCYTOMA |